Position in ATAI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$579,700
+$402,700 QoQ
Shares Held
110,000
+120.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#75
of 239 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MYDA Advisors LLC holds $47,243,871 across 14 Biotechnology names. ATAI ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
1,150,000 | $17,112,000 | |
| 2 | MANE |
Veradermics, Inc
|
100,000 | $12,294,000 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
240,000 | $6,292,800 | |
| 4 | EYPT |
EyePoint, Inc.
|
250,000 | $3,575,000 | |
| 5 | BNTC |
Benitec Biopharma Inc.
|
250,000 | $3,345,000 | |
| 6 | PROK |
Prokidney Corp.
|
640,775 | $1,307,181 | |
| 7 | IMTX |
Immatics N.V.
|
120,000 | $1,215,600 | |
| 8 | INSM |
INSMED Inc
|
7,000 | $746,340 |
All Filings in ATAI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,700 | 110,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $177,000 | 50,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||